PlainPharmaWatch

CMS Open Payments · Program Year 2024

Pyros Pharmaceuticals, Inc.

Pyros Pharmaceuticals, Inc. reported $9,689.65 in payments to 260 physicians and teaching hospitals across 260 transactions.

$9.7K
Total payments
260
Transactions
260
Recipients
+$3.6K
General Payments vs PY2023

Pyros Pharmaceuticals, Inc. reported $9,689.65 in payments to 260 physicians and teaching hospitals in CMS Open Payments Program Year 2024 - ranking #1648 of 1,925 reporting manufacturers (0.0% of all US industry payments), averaging $37.27 per recipient across 1 payment categories. Figures are company-reported under the Physician Payments Sunshine Act; a reported payment is a financial relationship, not evidence of wrongdoing.

Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.

The verdict

Pyros Pharmaceuticals, Inc. pairs modest payment volume with an unusually diversified payment pattern across a wide recipient base.

#1648
of 1,925 companies
0.0%
of all US industry payments
0.0%
paid to its single top recipient
1
payment categories

Release-over-release change

General Payments changed from PY2023 to PY2024

Pyros Pharmaceuticals, Inc.'s CMS-reported General Payments increased by $3.6K (+58.0%) from PY2023 to PY2024. The comparison uses the same CMS manufacturer-by-payment-category summary for both years and excludes research and ownership or investment records.

CMS source labels for this exact identifier: PY2023: PYROS PHARMACEUTICALS, INC.PY2024: Pyros Pharmaceuticals, Inc.. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.

Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.

General Payments: PY2023 vs PY2024

Annual CMS-reported totals for this company, not an all-category Open Payments total

PY2023$6.1KPY2024$9.7K
PY2023
$6,132.39
PY2024
$9,689.65

How Pyros Pharmaceuticals, Inc. ranks nationally

Where this company's total reported payments fall within the full national distribution of all 1,925 companies in CMS Open Payments, not just its nearest peers.

Pyros Pharmaceuticals, Inc.'s total vs. every reporting company

CMS Open Payments, Program Year 2024

$9,690 14th percentile higher than 14% of 1,925 reporting companies

$9–$28: 3 reporting companies (0%). Below this entry. $28–$87: 10 reporting companies (1%). Below this entry. $87–$270: 20 reporting companies (1%). Below this entry. $270–$838: 41 reporting companies (2%). Below this entry. $838–$2,603: 76 reporting companies (4%). Below this entry. $2,603–$8,084: 114 reporting companies (6%). Below this entry. $8,084–$25,112: 167 reporting companies (9%). This entry sits in this band. $25,112–$78,003: 249 reporting companies (13%). Above this entry. $78,003–$242,294: 295 reporting companies (15%). Above this entry. $242,294–$752,621: 270 reporting companies (14%). Above this entry. $752,621–$2,337,813: 263 reporting companies (14%). Above this entry. $2,337,813–$7,261,783: 200 reporting companies (10%). Above this entry. $7,261,783–$22,556,757: 133 reporting companies (7%). Above this entry. $22,556,757–$70,066,439: 45 reporting companies (2%). Above this entry. $70,066,439–$217,642,369: 26 reporting companies (1%). Above this entry. $217,642,369–$676,046,922: 13 reporting companies (1%). Above this entry. This company $9 $676,046,922 every reporting company, bucketed by value

Each bar is a progressively wider band; taller bars hold more reporting companies. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Open Payments · 2024

What the Data Shows for Pyros Pharmaceuticals, Inc.

$9,689.65: that is what Pyros Pharmaceuticals, Inc. reported in payments to 260 physicians and teaching hospitals during Program Year 2024, spread across 260 transactions ($37.27 per transaction, $37.27 per recipient). The company sits at rank #1648 of 1,925, a comparatively small 0.0% slice of all industry payments reported nationwide for the year.

"Food and Beverage" leads the 1-category general-payment breakdown below at $9.7K (100.0% of the company's reported total, 260 transactions) - see our methodology for how research and ownership payments are reported separately.

General Payment Breakdown by Type

Pyros Pharmaceuticals, Inc. made 1 types of general payments. "Food and Beverage" is the largest category at $9.7K, 100.0% of the company's reported total.

How Pyros Pharmaceuticals, Inc. divides its payments

General-payment categories, ordered by reported total

1. Food and Beverage$9.7K
Payment Type Amount Transactions
Food and Beverage $9.7K 260

Recipient Concentration in General Payments

The five largest recipient relationships account for $1,338.97 (13.8%) of $9,689.65 in this company's General Payments records across 179 recipients. This is a CMS Open Payments Program Year 2024 General Payments view only: it excludes research and ownership/investment records, so it is not the all-category company total above.

Largest General-Payment relationships for Pyros Pharmaceuticals, Inc.

The five named recipients with the highest reported General Payments from this company

Osman Farooq$482.01Jennifer Mcvige$233.45Beck Leslie Espiritu$208.31Aran Groves$208.31Khalid Kakish$206.89
  1. 1

    Osman Farooq

    $482.01 across 2 reported transactions

  2. 2

    Jennifer Mcvige

    $233.45 across 2 reported transactions

  3. 3

    Beck Leslie Espiritu

    $208.31 across 3 reported transactions

  4. 4

    Aran Groves

    $208.31 across 3 reported transactions

  5. 5

    Khalid Kakish

    $206.89 across 2 reported transactions

Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.

Payment Size Analysis

Average transaction size: $37.27. Average per recipient: $37.27.

Total Amount

$9,689.65

Avg per Transaction

$37.27

Avg per Recipient

$37.27

Payment Transparency Context

What is the Sunshine Act?

The Physician Payments Sunshine Act (part of the Affordable Care Act) requires pharmaceutical and medical device manufacturers to report payments and transfers of value to physicians and teaching hospitals. These payments can include consulting fees, research grants, speaker fees, food and beverages, travel, royalties, and other forms of compensation.

Industry Total (2024)

$13.9B

across 1,925 companies

Pyros Pharmaceuticals, Inc. Share

0.0%

#1648 by total payments

Frequently Asked Questions

How much did Pyros Pharmaceuticals, Inc. pay to physicians and hospitals in 2024?
0.0% of all industry payments reported to CMS Open Payments for 2024 came from Pyros Pharmaceuticals, Inc., totaling $9,689.65 across 260 transactions to physicians and hospitals.
How many physicians received payments from Pyros Pharmaceuticals, Inc.?
260 physicians and teaching hospitals received payments from Pyros Pharmaceuticals, Inc. in 2024, averaging $37.27 per recipient.
What types of payments did Pyros Pharmaceuticals, Inc. make?
Pyros Pharmaceuticals, Inc. made 1 different types of general payments (consulting, meals, travel, and similar categories). The largest general-payment category was "Food and Beverage" at $9.7K, representing 100.0% of the company's reported total.
How does Pyros Pharmaceuticals, Inc. rank among pharmaceutical companies?
Out of 1,925 companies in the CMS Open Payments database for 2024, Pyros Pharmaceuticals, Inc. ranks #1648 by total payment amount.
What is the average payment size from Pyros Pharmaceuticals, Inc.?
In 2024, Pyros Pharmaceuticals, Inc. averaged $37.27 per transaction across 260 transactions to 260 recipients.
Where does the payment data for Pyros Pharmaceuticals, Inc. come from?
This data comes from the CMS Open Payments program (Sunshine Act), which requires pharmaceutical and medical device companies to report payments and transfers of value to physicians and teaching hospitals. The data covers Program Year 2024.

Data Source: Centers for Medicare & Medicaid Services (CMS) Open Payments, Program Year 2024. Data includes general payments, research payments, and physician ownership/investment interests as required by the Physician Payments Sunshine Act. Total industry payments: $13.9B across 1,925 companies.

Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch Editorial
Disclaimer

This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.

View saved (companies)
Download Pyros Pharmaceuticals, Inc.'s data (CSV)
Embed this widget

Copy this snippet to embed a live-linked card on your own site.

Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-25.